Tag Archives: U.S.

Pfizer’s keys to juggling 8 U.S. launches? Organization, accountability, clear goals

Think you’re busy? Take a look at Pfizer’s commercial team for oncology, which is currently launching four new drugs, three new indications for older drugs, and a biosimilar. And that’s just in the U.S. It’s taken some serious internal organizing on Pfizer’s part, but so far managing the multiple rollouts has been “done very well,”… Read More »

U.S. government proposes rule changing drug industry rebate system

FILE PHOTO: U.S. President Donald Trump speaks to the media with U.S. Senate Majority Leader Mitch McConnell at his side in the Rose Garden of the White House in Washington, U.S., October 16, 2017. REUTERS/Kevin Lamarque NEW YORK (Reuters) – The U.S. government on Thursday proposed a rule to end the industry-wide system of after-market… Read More »